Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death

ASN Neuro

Volumn 5, Issue 1, 2013, Pages 13-26

  Miller, Nichole M ^a   Shriver, Leah P ^a   Bodiga, Vijaya L ^a   Ray, Avijit ^a   Basu, Sreemanti ^a   Ahuja, Rajiv ^a   Jana, Arundhati ^b   Pahan, Kalipada ^b   Dittel, Bonnie N ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Axonopathies; CD4 T cell; CD8 T cell; Multiple sclerosis; Neurodegeneration; NK cells

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL GRANULE; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; DENDRITE; EMBRYO; IMMUNOPATHOGENESIS; INTRACELLULAR SIGNALING; LYMPHOCYTOTOXICITY; MICROTUBULE AXONAL DESTABILIZATION; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPATHY; NONHUMAN; TH1 CELL; TH17 CELL;

EID: 84874861806     PISSN: 17590914     EISSN: None     Source Type: Journal    
DOI: 10.1042/AN20120087     Document Type: Article

References (98)

1. Aboul-Enein F., Weiser P, Hoftberger R, Lassmann H, Bradl M (2006) Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol 111:539-547.
2. Aktas O., Smorodchenko A, Brocke S, Infante-Duarte C, Topphoff US, Vogt J, Prozorovski T., Meier S, Osmanova V, Pohl E, Bechmann I, Nitsch R, Zipp F (2005) Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 46:421-432.
3. Al-Falahi Y., Sand KL, Knudsen E, Damaj BB, Rolin J, Maghazachi AA (2009) Splenic natural killer cell activity in two models of experimental neurodegenerative diseases. J Cell Mol Med 13:2693-2703.
4. Anderson JM., Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, Franklin RJ., Giovannoni G, Compston DA, Baker D, Spillantini MG, Chandran S (2008) Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 131:1736-1748.
5. Anderson JM., Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S (2010) Abnormal tau phosphorylation in primary progressive multiple sclerosis. Acta Neuropathol 119:591-600.
6. Awane M., Andres PG, Li DJ, Reinecker HC (1999) NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 162:5337-5344.
7. +T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393-404.
8. Backstrom E., Chambers BJ, Ho EL, Naidenko OV, Mariotti R, Fremont DH, Yokoyama WM., Kristensson K, Ljunggren HG (2003) Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol 33:92-100.
9. Barbosa MD., Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, Brandt SJ., Chotai D, Hodgman C, Solari RC, Lovett M, Kingsmore SF (1996) Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 382:262-265.
10. Bitsch A., Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123:1174-1183.
11. Bjartmar C., Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171.
12. Boiko T., Vakulenko M, Ewers H, Yap CC, Norden C, Winckler B (2007) Ankyrin-dependent and-independent mechanisms orchestrate axonal compartmentalization of L1 family members neurofascin and L1/neuron-glia cell adhesion molecule. J Neurosci 27:590-603.
13. Borregaard N., Heiple JM, Simons ER, Clark RA (1983) Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Bio 97:52-61.
14. Campbell GR., Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H., Turnbull DM, Mahad DJ (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481-492.
15. Chevalier G., Suberbielle E, Monnet C, Duplan V, Martin-Blondel G, Farrugia F, Le Masson G, Liblau R, Gonzalez-Dunia D (2011) Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog 7:e1002393.
16. Ciccarelli O., Toosy AT, De Stefano N, Wheeler-Kingshott CA, Miller DH, Thompson AJ (2010) Assessing neuronal metabolism in vivo by modeling imaging measures. J Neurosci 30:15030-15033.
17. Coleman MP., Adalbert R, Beirowski B (2005) Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice. J Neurol Sci 233:133-138.
18. Compston A., Coles A (2008) Multiple sclerosis. Lancet 372:1502-1517.
19. Conde C., Caceres A (2009) Microtubule assembly, organization and dynamics in axons and dendrites. Nat Rev Neurosci 10:319-332.
20. DeLuca GC., Williams K, Evangelou N, Ebers GC, Esiri MM (2006) The contribution of demyelination to axonal loss in multiple sclerosis. Brain 129:1507-1516.
21. Dittel BN., Merchant RM, Janeway, Jr., CA (1999) Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 162:6392-6400.
22. Dittel BN., Sant'Angelo DB, Janeway, Jr., CA (1997) Peptide antagonists inhibit proliferation and the production of IL-4 and/or IFN-γ in T helper 1, T helper 2, and T helper 0 clones bearing the same TCR. J Immunol 158:4065-4073.
23. Edwards LJ., Robins RA, Constantinescu CS (2010) Th17/Th1 phenotype in demyelinating disease. Cytokine 50:19-23.
24. El-Behi M., Ciric B, Dai H, Yan Y, Cullimore M, Safavi F, Zhang GX, Dittel BN, Rostami A (2011) The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12:568-575.
25. El-Behi M., Rostami A, Ciric B (2010) Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 5:189-197.
26. Ferguson B., Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
27. Funfschilling U., Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG., Kassmann CM, Tzvetanova ID, Mobius W, Diaz F, Meijer D, Suter U., Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517-521.
28. Giuliani F., Goodyer CG, Antel JP, Yong VW (2003) Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 171:368-379.
29. +T cell attack. Glia 58:469-480.
30. Guzik BW., Goldstein LS (2004) Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction. Curr Opin Cell Biol 16:443-450.
31. Haile Y., Simmen KC, Pasichnyk D, Touret N, Simmen T, Lu JQ, Bleackley RC, Giuliani F (2011) Granule-derived granzyme B mediates the vulnerability of human neurons to T cell-induced neurotoxicity. J Immunol 187:4861-4872.
32. Hammarberg H., Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A., Linda H, van Der Meide PH, Cullheim S, Olsson T, Piehl F (2000) Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20:5283-5291.
33. Hao J., Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI, Xiang R, La Cava A, Van Kaer L, Shi FD (2010) Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 207:1907-1921.
34. Hedegaard CJ., Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH (2008) T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology 125:161-169.
35. Herz J., Zipp F, Siffrin V (2009) Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225:9-17.
36. Hirokawa N., Niwa S, Tanaka Y (2010) Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68:610-638.
37. Hu D., Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5:516-523.
38. Huang D., Shi FD, Jung S, Pien GC, Wang J, Salazar-Mather TP, He TT, Weaver JT, Ljunggren HG, Biron CA, Littman DR, Ransohoff RM (2006) The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 20:896-905.
39. +T cells in a model for multiple sclerosis. J Exp Med 194:669-676.
40. Jahng AW., Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y., Kumar V (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 194:1789-1799.
41. Jana A., Pahan K (2004) Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J Neurosci 24:9531-9540.
42. Jana A., Pahan K (2010) Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease. J Neurosci 30:12676-12689.
43. +T cells. Ann N Y Acad Sci 1103:157-166.
44. Johnson GV., Stoothoff WH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117:5721-5729.
45. Kaech S., Banker G (2006) Culturing hippocampal neurons. Nat Protoc 1:2406-2415.
46. Kanai Y., Hirokawa N (1995) Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron 14:421-432.
47. Kang Z., Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H, Liu L, Qian W, Ransohoff RM., Bergmann C, Stohlman S, Tuohy VK, Li X (2010) Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32:414-425.
48. Kaplan J., De Domenico I, Ward DM (2008) Chediak-Higashi syndrome. Cur Opin Hematol 15:22-29.
49. Kaur G., Trowsdale J, Fugger L (2012) Natural killer cells and their receptors in multiple sclerosis. Brain doi: 10.1093/brain/aws159.
50. Kebir H., Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F., Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173-1175.
51. Khoruts A., Miller SD, Jenkins MK (1995) Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J Immunol 155:5011-5017.
52. Kordeli E., Lambert S, Bennett V (1995) Ankyrin G. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. J Biol Chem 270:2352-2359.
53. Kornek B., Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
54. Kosik KS., Finch EA (1987) MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J Neurosci 7:3142-3153.
55. Kuhlmann T., Lingfeld G, Bitsch A, Schuchardt J, Bruck W (2002) Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125:2202-2212.
56. Lassmann H (2010) Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 225:2-8.
57. Lee Y., Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-448.
58. Lovett-Racke AE, Yang Y, Racke MK (2011) Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta 1812:246-251.
59. +T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26:593-604.
60. Masson D., Tschopp J (1985) Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem 260:9069-9072.
61. Matsumoto Y., Kohyama K, Aikawa Y, Shin T, Kawazoe Y, Suzuki Y, Tanuma N (1998) Role of natural killer cells and TCRγδ T cells in acute autoimmune encephalomyelitis. Eur J Immunol 28:1681-1688.
62. McQualter JL., Darwiche R, Ewing C, Onuki M, Kay TW, Hamilton JA, Reid HH, Bernard CC (2001) Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med 194:873-882.
63. Meares GP., Ma X, Qin H, Benveniste EN (2012) Regulation of CCL20 expression in astrocytes by IL-6 and IL-17. Glia 60:771-781.
64. Medana I., Martinic MA, Wekerle H, Neumann H (2001) Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 159:809-815.
65. +T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur J Immunol 30:3623-3633.
66. Miller E (2012) Multiple sclerosis. Adv Exp Med Biol 724:222-238.
67. Montes M., Zhang X, Berthelot L, Laplaud DA, Brouard S, Jin J, Rogan S, Armao D, Jewells V, Soulillou JP, Markovic-Plese S (2009) Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol 130:133-144.
68. Morfini GA., Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, Brown RH Jr, Brown H, Tiwari A, Hayward L, Edgar J, Nave KA, Garberrn J, Atagi Y, Song Y., Pigino G, Brady ST (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29:12776-12786.
69. Murray PD., McGavern DB, Lin X, Njenga MK, Leibowitz J, Pease LR, Rodriguez M (1998) Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci 18:7306-7314.
70. Neumann H (2003) Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr Opin Neurol. 16:267-273.
71. Nikic I., Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Bruck W, Bishop D, Misgeld T, Kerschensteiner M (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495-499.
72. Nylander A., Hafler DA (2012) Multiple sclerosis. J Clin Invest 122:1180-1188.
73. Podack ER., Konigsberg PJ (1984) Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization. J Exp Med 160:695-710.
74. Ponomarev ED., Shriver LP, Maresz K, Pedras-Vasconcelos J, Verthelyi D, Dittel BN (2007) GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol 178:39-48.
75. Ransom BR., Neale E, Henkart M, Bullock PN, Nelson PG (1977) Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties. J Neurophysiol 40:1132-1150.
76. Ray A., Basu S, Williams CB, Salzman NH, Dittel BN (2012) A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 188:3188-3198.
77. Regunathan J., Chen Y, Wang D, Malarkannan S (2005) NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. Blood 105:233-240.
78. Roder JC., Lohmann-Matthes ML, Domzig W, Wigzell H (1979) The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol 123:2174-2181.
79. Saikali P., Antel JP, Newcombe J, Chen Z, Freedman M, Blain M, Cayrol R, Prat A, Hall JA, Arbour N (2007) NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci 27:1220-1228.
80. Schneider A., Araujo GW, Trajkovic K, Herrmann MM, Merkler D, Mandelkow EM, Weissert R, Simons M (2004) Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis. J Biol Chem 279:55833-55839.
81. Sepulcre J., Sastre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thompson AJ (2006) Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 63: 1175-1180.
82. +T-cell-mediated control of West Nile virus infection in the central nervous system. J Virol 81:11749-11757.
83. Shriver LP., Dittel BN (2006) T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Am J Pathol 169:999-1011.
84. Siffrin V., Radbruch H, Glumm R, Niesner R, Paterka M, Herz J, Leuenberger T, Lehmann SM., Luenstedt S, Rinnenthal JL, Laube G, Luche H, Lehnardt S., Fehling HJ, Griesbeck O, Zipp F (2010a) In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33:424-436.
85. Siffrin V., Vogt J, Radbruch H, Nitsch R, Zipp F (2010b) Multiple sclerosis-candidate mechanisms underlying CNS atrophy. Trends Neurosci 33:202-210.
86. Singh AK., Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S., Koezuka Y, Van Kaer L (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194:1801-1811.
87. Sospedra M., Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747.
88. +T cells in the latently infected trigeminal ganglia. J Immunol 176:1703-1711.
89. Tallantyre EC., Bo L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N (2009) Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 132:1190-1199.
90. Thiery J., Walch M, Jensen DK, Martinvalet D, Lieberman J (2010) Isolation of cytotoxic T cell and NK granules and purification of their effector proteins. Curr Protoc Cell Biol 43:3.37.1-3.37.29.
91. Traugott U., Reinherz EL, Raine CS (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308-310.
92. Trushina E., Dyer RB, Badger JD II, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V., McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S., McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I., Doyle K, Bender A, Chacko C, McMurray CT (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195-8209.
93. Tzartos JS., Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172:146-155.
94. Vogt J., Paul F, Aktas O, Muller-Wielsch K, Dorr J, Dorr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F (2009) Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol 66:310-322.
95. Winkler-Pickett R., Young HA, Cherry JM, Diehl J, Wine J, Back T, Bere WE, Mason AT., Ortaldo JR (2008) In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J Immunol 180:4495-4506.
96. Yodoi J., Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M., Minato N, Tsudo M, Uchiyama T, Maeda M (1985) TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 134:1623-1630.
97. +T cells in experimental autoimmune encephalomyelitis. J Autoimmun 35:33-44.
98. Zhang B., Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186:1677-1687.